A sweeping antitrust lawsuit, filed last month by 43 state attorneys general accusing the world’s biggest generic drug manufacturers of fixing prices on dozens of drugs, has identified the alleged key player. Maureen Cavanaugh, a former senior vice president at Teva Pharmaceuticals, is accused of colluding to raise prices, as much as 1,000% in some cases, on 107 different generic drugs. While not identified as the mastermind behind the five-year-long price-fixing conspiracy, Cavanaugh stands out due to the sheer number of drugs she is alleged to have colluded on to fix prices.  Learn More